# | Title | Journal | Year | Citations |
---|
1 | Rheumatoid arthritis | Nature Reviews Disease Primers | 2018 | 1,441 |
2 | EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs | Annals of the Rheumatic Diseases | 2010 | 1,429 |
3 | 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus | Annals of the Rheumatic Diseases | 2019 | 759 |
4 | Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis | Annals of the Rheumatic Diseases | 2011 | 394 |
5 | EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases | Annals of the Rheumatic Diseases | 2007 | 325 |
6 | Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system | Blood | 2009 | 269 |
7 | Interleukin-22 protects intestinal stem cells against genotoxic stress | Nature | 2019 | 251 |
8 | Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis | Arthritis and Rheumatism | 2007 | 249 |
9 | Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients | Science Immunology | 2021 | 223 |
10 | EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases | Annals of the Rheumatic Diseases | 2013 | 220 |
11 | Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis | Annals of the Rheumatic Diseases | 2020 | 205 |
12 | Evidence for treating rheumatoid arthritis to target: results of a systematic literature search | Annals of the Rheumatic Diseases | 2010 | 203 |
13 | The association between rheumatoid arthritis and periodontal disease | Arthritis Research and Therapy | 2010 | 184 |
14 | Molecular mechanisms of glucocorticoid-induced osteoporosis | Bone | 2001 | 171 |
15 | Validation of the Mobile Application Rating Scale (MARS) | PLoS ONE | 2020 | 149 |
16 | Photopolymerizable gelatin and hyaluronic acid for stereolithographic 3D bioprinting of tissue‐engineered cartilage | Journal of Biomedical Materials Research - Part B Applied Biomaterials | 2019 | 139 |
17 | Frequency of disease-associated and other nuclear autoantibodies in patients of the German network for systemic scleroderma: correlation with characteristic clinical features | Arthritis Research and Therapy | 2011 | 133 |
18 | Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry | Annals of the Rheumatic Diseases | 2022 | 130 |
19 | Current evidence for a strategic approach to the management of rheumatoid arthritis with disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis | Annals of the Rheumatic Diseases | 2010 | 126 |
20 | European S3‐Guideline on the systemic treatment of psoriasis vulgaris – Update Apremilast and Secukinumab – EDF in cooperation with EADV and IPC | Journal of the European Academy of Dermatology and Venereology | 2017 | 116 |
21 | IFNα and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus | Annals of the Rheumatic Diseases | 2013 | 115 |
22 | Delays in assessment of patients with rheumatoid arthritis: variations across Europe | Annals of the Rheumatic Diseases | 2011 | 112 |
23 | Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients | Arthritis Research and Therapy | 2009 | 108 |
24 | Magnetic resonance imaging of active sacroiliitis: Do we really need gadolinium? | European Journal of Radiology | 2009 | 98 |
25 | Repeated administration of dapirolizumab pegol in a randomised phase I study is well tolerated and accompanied by improvements in several composite measures of systemic lupus erythematosus disease activity and changes in whole blood transcriptomic profiles | Annals of the Rheumatic Diseases | 2017 | 97 |
26 | Nutritional status as marker for disease activity and severity predicting mortality in patients with systemic sclerosis | Annals of the Rheumatic Diseases | 2010 | 90 |
27 | Optimized glucocorticoid therapy: Teaching old drugs new tricks | Molecular and Cellular Endocrinology | 2013 | 89 |
28 | B and T Cell Responses after a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients | Journal of the American Society of Nephrology: JASN | 2021 | 82 |
29 | Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other rheumatic diseases (May 2002) | Annals of the Rheumatic Diseases | 2002 | 70 |
30 | The multifaceted balance of TNF-α and type I/II interferon responses in SLE and RA: how monocytes manage the impact of cytokines | Journal of Molecular Medicine | 2012 | 67 |
31 | Glucocorticoids | Best Practice and Research in Clinical Rheumatology | 2011 | 65 |
32 | The majority of newly diagnosed patients with juvenile idiopathic arthritis reach an inactive disease state within the first year of specialised care: data from a German inception cohort | RMD Open | 2015 | 63 |
33 | Tissue engineering in the rheumatic diseases | Arthritis Research and Therapy | 2009 | 60 |
34 | Urinary CD4 T cells identify SLE patients with proliferative lupus nephritis and can be used to monitor treatment response | Annals of the Rheumatic Diseases | 2014 | 60 |
35 | Monocyte alterations in rheumatoid arthritis are dominated by preterm release from bone marrow and prominent triggering in the joint | Annals of the Rheumatic Diseases | 2018 | 59 |
36 | Effects of curcumin supplementation on blood glucose, insulin resistance and androgens in patients with polycystic ovary syndrome: A randomized double-blind placebo-controlled clinical trial | Phytomedicine | 2021 | 59 |
37 | Current state and future directions of autologous hematopoietic stem cell transplantation in systemic lupus erythematosus | Annals of the Rheumatic Diseases | 2011 | 58 |
38 | Canakinumab for Treatment of Adult-Onset Still’s Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial | Annals of the Rheumatic Diseases | 2020 | 56 |
39 | In vivo effect of bone marrow-derived mesenchymal stem cells in a rat kidney transplantation model with prolonged cold ischemia | Transplant International | 2011 | 55 |
40 | B Cell Numbers Predict Humoral and Cellular Response Upon SARS–CoV‐2 Vaccination Among Patients Treated With Rituximab | Arthritis and Rheumatology | 2022 | 55 |
41 | Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis | RMD Open | 2023 | 50 |
42 | Are interferon-related biomarkers advantageous for monitoring disease activity in systemic lupus erythematosus? A longitudinal benchmark study | Rheumatology | 2017 | 49 |
43 | Blood dendritic cells in systemic lupus erythematosus exhibit altered activation state and chemokine receptor function | Annals of the Rheumatic Diseases | 2010 | 48 |
44 | The cellular signature of urinary immune cells in Lupus nephritis: new insights into potential biomarkers | Arthritis Research and Therapy | 2015 | 48 |
45 | Follow-up standards and treatment targets in rheumatoid arthritis: results of a questionnaire at the EULAR 2008 | Annals of the Rheumatic Diseases | 2010 | 47 |
46 | Response to: ‘‘2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus’ by Aringeret al’ by Cuiet al | Annals of the Rheumatic Diseases | 2022 | 47 |
47 | Diagnostic value of anti-topoisomerase I antibodies in a large monocentric cohort | Arthritis Research and Therapy | 2009 | 45 |
48 | Loss of methylation at the IFNG promoter and CNS‐1 is associated with the development of functional IFN‐γ memory in human CD4+T lymphocytes | European Journal of Immunology | 2013 | 44 |
49 | Analysis of distribution and severity of inflammation in patients with osteoarthitis compared to rheumatoid arthritis by ICG-enhanced fluorescence optical imaging and musculoskeletal ultrasound: a pilot study | Annals of the Rheumatic Diseases | 2016 | 44 |
50 | Hematopoietic Stem Cell Transplantation for Autoimmune Disease | Annual Review of Medicine | 2021 | 44 |